A multicentre, prospective, study to evaluate the safety and efficacy of PEGEPO (Pegylated Erythropoietin) in healthy volunteers and patients with chronic renal failure.
Latest Information Update: 12 Nov 2019
At a glance
- Drugs Recombinant erythropoietin (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Zydus Lifesciences
- 01 Sep 2016 New trial record